Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Ultrasound contrast agent
Patent
1997-06-26
1999-06-01
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Ultrasound contrast agent
424 952, 424450, 514 78, 514121, A61B 813
Patent
active
059086106
ABSTRACT:
Disclosed are injectable suspensions of gas filled microbubbles in an aqueous carrier liquid usable as contrast agents in ultrasonic echography. The suspensions comprise amphipathic compounds of which at least one may be a laminarized phospholipid as a stabiliser of the microbubbles against collapse with time and pressure. The concentration of phospholipids in the carrier liquid is below 0.01% wt but is at least equal to or above that at which phospholipid molecules are present solely at the gas microbubble-liquid interface. Also disclosed is a method of preparation of the stable suspensions of air or gas filled microbubbles.
REFERENCES:
patent: 4256251 (1981-03-01), Moshofsky
patent: 4276885 (1981-07-01), Tickner et al.
patent: 4316391 (1982-02-01), Tickner
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4572203 (1986-02-01), Feinstein
patent: 4657756 (1987-04-01), Rasor et al.
patent: 4681119 (1987-07-01), Rasor et al.
patent: 4684479 (1987-08-01), D'Arrigo
patent: 4718433 (1988-01-01), Feinstein
patent: 4774958 (1988-10-01), Feinstein
patent: 4832941 (1989-05-01), Berwing et al.
patent: 4844882 (1989-07-01), Widder et al.
patent: 4900540 (1990-02-01), Ryan et al.
patent: 4957656 (1990-09-01), Cerny et al.
patent: 5088499 (1992-02-01), Unger
patent: 5137928 (1992-08-01), Erbel et al.
patent: 5141738 (1992-08-01), Rasor et al.
patent: 5147631 (1992-09-01), Glajch et al.
patent: 5195520 (1993-03-01), Schlief et al.
patent: 5271928 (1993-12-01), Schneider et al.
patent: 5352436 (1994-10-01), Wheatley et al.
patent: 5425366 (1995-06-01), Reinhardt et al.
patent: 5501863 (1996-03-01), Rossling et al.
patent: 5599523 (1997-02-01), Beller et al.
Swanson, pp. 682-687 "Chapter 22: Enhancement Agents for Ultrasound: Fundamentals" in Pharmaceuticals in Medical Imaging, (Eds. Swanson et al., MacMillan Publishing Company, New York, 1990).
Lincoff et al Intravitreal Longevity of Three Perfluorocarbon Gases, Arch. Ophthalmology, 98: 1610-1611(1980).
Lincoff et al Intravitreal Expansion of Pefluorocarbon Bubbles, Arch. Ophthalmology, 98: 1646(1980).
Lincoff et al The Perfluorocarbon Gases in the Treatment of Retinal Detachment, Ophthalmology, 90(5):546-551(1983).
Lincoff et al Perfluoro-n-butane: A Gas for Maximum Duration Retinal Temponade, Arch Ophthalmology, 101:460-463(1983).
Gardner et al (1988) "Survey of Intraocular Gas Use in North America," Arch Ophthalmol, 106:1188-1189.
Brochot Jean
Puginier Jerome
Schneider Michel
Yan Feng
Bracco International B.V.
Hollinden Gary E.
LandOfFree
Stable microbubble suspensions comprising saturated phospholipio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable microbubble suspensions comprising saturated phospholipio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable microbubble suspensions comprising saturated phospholipio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-953440